Cited by 601Marine Sponges and Natural ProductsMicrobial Natural Products and BiosynthesisIsoquinoline Alkaloid Synthesis

The DOI matches its Crossref record; 74 of the 77 references it cites were found in a registry or an index.

Marine natural products as anticancer drugs

Simmons, T. Luke, Andrianasolo, Eric, McPhail, Kerry, Flatt, Patricia, Gerwick, William H.·2005·Molecular Cancer Therapeutics

DOI 10.1158/1535-7163.333.4.2

Open this paper in CoChat — free account

Abstract

The chemical and biological diversity of the marine environment is immeasurable and therefore is an extraordinary resource for the discovery of new anticancer drugs. Recent technological and methodologic advances in structure elucidation, organic synthesis, and biological assay have resulted in the isolation and clinical evaluation of various novel anticancer agents. These compounds range in structural class from simple linear peptides, such as dolastatin 10, to complex macrocyclic polyethers, such as halichondrin B; equally as diverse are the molecular modes of action by which these molecules impart their biological activity. This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.

Integrity signals

Registry

Crossref · 10.1158/1535-7163.333.4.2

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Environmental genome shotgun sequencing of the sargasso sea
Venter, J. C., Remington, K., Heidelberg, J. F., Halpern, A. L., Rusch, D., Eisen, J. A., Wu, D., Paulsen, I., Nelson, K. E., Nelson, W., et al. (2004) · Science · doi:10.1126/science.1093857 · Cited by 4,376
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Newman, D. J., & Cragg, G. M. L. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 758
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A. M., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4 · Cited by 678
The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583
Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata
RINEHART, K. L. J., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F.-R., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 493
In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.
Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483
Palytoxin: A New Marine Toxin from a Coelenterate
Moore, R. E., & Scheuer, P. J. (1971) · Science · doi:10.1126/science.172.3982.495 · Cited by 482
Natural products ? a simple model to explain chemical diversity
Firn, R. D., & Jones, C. G. (2003) · Natural Product Reports · doi:10.1039/b208815k · Cited by 467
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
Bai, R., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 380

Show all 77 references

Research works printed but not linked: 3

Armand JP, Ady-Vago N, Faivre S, et al. Phase I and Pharmacokinetic Study of Aplidine (APL) given as a 24-hour continuous infusion every other week (q2w) in patients (pts) with solid tumor (ST) and lymphoma (NHL). Proceedings of the 2001 American Society of Clinical Oncology Annual Meeting. Abstr #47. In 2001.
Dileo P, Casali PG, Bacci G, et al. Phase II evaluation of 3-hr infusion ET-743 in patients with recurrent sarcomas. Proceedings of the 2002 ASCO Annual Meeting. Abstr #1628. In 2002.
Kimura T, Synold T, Mahaffey CM, et al. E7389, a novel antimicrotubule agent with potent p53-independent induction of p27, Bcl2 phosphorylation and cytotoxicity in non-small cell lung cancer (NSCLC). Proceedings of the American Society of Clinical Oncology. Abstr. # 2804. In 2003. p. 697.

Sorted by citations

Sponge-Associated Microorganisms: Evolution, Ecology, and Biotechnological Potential
Taylor, M. W., Radax, R., Steger, D., & Wagner, M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-06 · Cited by 1,493
Natural compounds for cancer treatment and prevention
Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., & Capaccioli, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.017 · Cited by 780
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 707
Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni , the cyanobacterial symbiont of Lissoclinum patella
Schmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., & Ravel, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501424102 · Cited by 567
Marine Natural Products: A Source of Novel Anticancer Drugs
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555
Engineering cyanobacteria to generate high-value products
Ducat, D. C., Way, J. C., & Silver, P. A. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.12.003 · Cited by 536
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Lichota, A., & Gwoździński, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113533 · Cited by 494
Small Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 466
Marine natural products
Blunt, J. W., Copp, B. R., Hu, W.-P., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2007) · Natural Product Reports · doi:10.1039/b603047p · Cited by 441
Marine Natural Products: A New Wave of Drugs?
Montaser, R., & Luesch, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.118 · Cited by 457
Phycobiliproteins from cyanobacteria: Chemistry and biotechnological applications
Pagels, F., Guedes, A. C., Amaro, H. M., Kijjoa, A., & Vasconcelos, V. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.010 · Cited by 426
Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs
Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405
Uncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects
Singh, R., Parihar, P., Singh, M., Bajguz, A., Kumar, J., Singh, S., Singh, V. P., & Prasad, S. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00515 · Cited by 399
Biotechnological and industrial significance of cyanobacterial secondary metabolites
Rastogi, R. P., & Sinha, R. P. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.04.009 · Cited by 371
Highly Efficient Cross‐Dehydrogenative‐Coupling between Ethers and Active Methylene Compounds
Zhang, Y., & LI, C. ‐. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503255 · Cited by 285
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals
Suárez-Jiménez, G. M., Burgos‐Hernández, A., & Ezquerra‐Brauer, J. M. (2012) · Marine Drugs · doi:10.3390/md10050963 · Cited by 276
Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents
Gezici, S., & Şekeroğlu, N. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666181224121004 · Cited by 258
Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting
Zhu, F., Chu, Q., Tao, L., Liu, X., Shi, Z., Ma, X., Jia, J., Tan, Y. C., Cui, C., Lin, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107336108 · Cited by 262
From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds
Alves, C., Silva, J., Pintéus, S., Gaspar, H., Alpoim, M. C., Botana, L. M., & Pedrosa, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00777 · Cited by 249
Recent advances in deep-sea natural products
Skropeta, D., & Wei, L. (2014) · Natural Product Reports · doi:10.1039/c3np70118b · Cited by 238
Marine genetic resources: A review of scientific and commercial interest
Leary, D., Vierros, M., Hamon, G., Aricò, S., & Monagle, C. (2008) · Marine Policy · doi:10.1016/j.marpol.2008.05.010 · Cited by 219
Biosynthetic origin of natural products isolated from marine microorganism–invertebrate assemblages
Simmons, T. L., Coates, R. C., Clark, B. R., Engene, N., Gonzalez, D. J., Esquenazi, E., Dorrestein, P. C., & Gerwick, W. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709851105 · Cited by 216
Pharmaceutical applications of cyanobacteria—A review
Vijayakumar, S., & Menakha, M. (2015) · Journal of Acute Medicine · doi:10.1016/j.jacme.2015.02.004 · Cited by 205
Sustainability and cyanobacteria (blue-green algae): facts and challenges
Sharma, N. K., Tiwari, S. P., Tripathi, K., & Rai, A. K. (2010) · Journal of Applied Phycology · doi:10.1007/s10811-010-9626-3 · Cited by 185
From anti-fouling to biofilm inhibition: New cytotoxic secondary metabolites from two Indonesian Agelas sponges
Hertiani, T., Edrada‐Ebel, R., Ortlepp, S., van Soest, R. W. M., de Voogd, N. J., Wray, V., Hentschel, U., Kozytska, S., Müller, W. E. G., & Proksch, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.028 · Cited by 177
Molluscan biological and chemical diversity: secondary metabolites and medicinal resources produced by marine molluscs
Benkendorff, K. (2010) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2010.00124.x · Cited by 176
Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells
Sanjeewa, K. K. A., Fernando, I. P. S., Kim, E.-A., Ahn, G., Jee, Y., & Jeon, Y.-J. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.1.3 · Cited by 171
Cyanobacteria: Model Microorganisms and Beyond
Allaf, M. M., & Peerhossaini, H. (2022) · Microorganisms · doi:10.3390/microorganisms10040696 · Cited by 168
Biologically active secondary metabolites from Actinomycetes
Solecka, J., Ziemska, J., Postek, M., & Rajnisz, A. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0036-1 · Cited by 162
Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future
Mazard, S., Penesyan, A., Ostrowski, M. D., Paulsen, I. T., & Egan, S. (2016) · Marine Drugs · doi:10.3390/md14050097 · Cited by 170
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes
Barreca, M., Spanò, V., Montalbano, A., Cueto, M., Díaz‐Marrero, A. R., Deniz, İ., Erdoğan, A., Bilela, L. L., Moulin, C., de Givenchy, E. T., et al. (2020) · Marine Drugs · doi:10.3390/md18120619 · Cited by 162
Anticancer Alkaloid Lamellarins Inhibit Protein Kinases
Baunbæk, D., Trinkler, N., Ferandin, Y., Lozach, O., Ploypradith, P., Rucirawat, S., Ishibashi, F., Iwao, M., & Meijer, L. (2008) · Marine Drugs · doi:10.3390/md20080026 · Cited by 147
Marine bacteria as source of antimicrobial compounds
Stincone, P., & Brandelli, A. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1710457 · Cited by 146
The stimulating adventure of KRN 7000
Banchet, A., Hénon, É., Dauchez, M., Renault, J., Monneaux, F., & Haudrechy, A. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00975j · Cited by 144
Anticancer activity of natural and synthetic acetylenic lipids
Dembitsky, V. M. (2006) · Lipids · doi:10.1007/s11745-006-5044-3 · Cited by 144
Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment
Abdel-Mageed, W. M., Milne, B. F., Wagner, M., Schumacher, M. M., Sándor, P., ., W. P.-A., Goodfellow, M., Bull, A. T., Horikoshi, K., Ebel, R., et al. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c001445a · Cited by 141
Multifunctional role of fucoidan, sulfated polysaccharides in human health and disease: A journey under the sea in pursuit of potent therapeutic agents
Pradhan, B., Patra, S., Nayak, R., Behera, C., Dash, S. R., Nayak, S., Sahu, B. B., Bhutia, S. K., & Jena, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.019 · Cited by 143
Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications
Sable, R. V., Parajuli, P., & Jois, S. D. S. (2017) · Marine Drugs · doi:10.3390/md15040124 · Cited by 139
Aurilides B and C, Cancer Cell Toxins from a Papua New Guinea Collection of the Marine Cyanobacterium Lyngbya majuscula
Han, B., Gross, H., Goeger, D. E., Mooberry, S. L., & Gerwick, W. H. (2006) · Journal of Natural Products · doi:10.1021/np0503911 · Cited by 133
A renaissance in marine pharmacology: From preclinical curiosity to clinical reality
Glaser, K. B., & Mayer, A. M. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.015 · Cited by 134
A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy
Bernardes, G. J. L., Casi, G., Trüssel, S., Hartmann, I., Schwager, K., Scheuermann, J., & Neri, D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201106527 · Cited by 133
Kinase Inhibitors of Marine Origin
Bharate, S. B., Sawant, S. D., Singh, P. P., & Vishwakarma, R. A. (2013) · Chemical Reviews · doi:10.1021/cr300410v · Cited by 132
Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery
Casi, G., Huguenin‐Dezot, N., Zuberbühler, K., Scheuermann, J., & Neri, D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211589m · Cited by 128
SZ‐685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway
Xie, G., Zhu, X., Li, Q., Gu, M., He, Z., Wu, J., Li, J., Lin, Y., Li, M., She, Z., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00577.x · Cited by 122
Cytotoxic Terpene Quinones from Marine Sponges
Gordaliza, M. (2010) · Marine Drugs · doi:10.3390/md8122849 · Cited by 122
Ready for a comeback of natural products in oncology
Bailly, C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.013 · Cited by 120
Cyanobacterial factories for the production of green energy and value-added products: An integrated approach for economic viability
Rajneesh, Singh, S. P., Pathak, J., & Sinha, R. P. (2016) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2016.11.110 · Cited by 121
High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview
Chakraborty, K., & Joy, M. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109637 · Cited by 116
The Natural Products Chemistry of Cyanobacteria
Tidgewell, K. J., Clark, B. R., & Gerwick, W. H. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00041-1 · Cited by 117
Synthesis of β-Carboline-BasedN-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells
Dighe, S. U., Khan, S. U., Soni, I., Jain, P., Shukla, S., Yadav, R., Sen, P., Meeran, S. M., & Batra, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00016 · Cited by 114
Bacterial Production of the Tunicate-Derived Antitumor Cyclic Depsipeptide Didemnin B
Tsukimoto, M., Nagaoka, M., Shishido, Y., Fujimoto, J., Nishisaka, F., Matsumoto, S., Harunari, E., Imada, C., & Matsuzaki, T. (2011) · Journal of Natural Products · doi:10.1021/np200543z · Cited by 114
Characterization of the Saframycin A Gene Cluster fromStreptomyces lavendulaeNRRL 11002 Revealing a Nonribosomal Peptide Synthetase System for Assembling the Unusual Tetrapeptidyl Skeleton in an Iterative Manner
Li, L., Deng, W., Song, J., Ding, W., Zhao, Q., Peng, C., Song, W.-W., Tang, G., & Liu, W. (2007) · Journal of Bacteriology · doi:10.1128/jb.00826-07 · Cited by 114
Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
Fanale, D., Bronte, G., Passiglia, F., Calò, V., Castiglia, M., Piazza, F. D., Barraco, N., Cangemi, A. G., Catarella, M. T., Insalaco, L., et al. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/690916 · Cited by 112
Cyanobacteria: potential candidates for drug discovery
Dixit, R. B., & Suseela, M. R. (2013) · Antonie van Leeuwenhoek · doi:10.1007/s10482-013-9898-0 · Cited by 120
Planctomycetes as Novel Source of Bioactive Molecules
Graça, A. P., Calisto, R., & Lage, O. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01241 · Cited by 109
Trabectedin: A Review of its Use in the Management of Soft Tissue Sarcoma and Ovarian Cancer
Carter, N. J., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767150-00009 · Cited by 107
Bioprospecting microbial natural product libraries from the marine environment for drug discovery
Liu, X., Ashforth, E. J., Ren, B., Song, F., Dai, H., Liu, M., Wang, J., Xie, Q., & Zhang, L. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.56 · Cited by 108
Ammosamides A and B Target Myosin
Hughes, C. C., MacMillan, J. B., Gaudêncio, S. P., Fenical, W., & Clair, J. J. L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200804107 · Cited by 108
Bioactive Natural Substances from Marine Sponges: New Developments and Prospects for Future Pharmaceuticals
Perdicaris, S., Vlachogianni, T., & Valavanidis, A. (2013) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000114 · Cited by 108
Anti-Inflammatory Activities of Natural Products Isolated from Soft Corals of Taiwan between 2008 and 2012
Wei, W., Sung, P., Duh, C., Chen, B., Sheu, J., & Yang, N. (2013) · Marine Drugs · doi:10.3390/md11104083 · Cited by 107
Marine natural products with anti-inflammatory activity
Cheung, R. C. F., Ng, T. B., Wong, J. H., Chen, Y., & Chan, W. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7244-3 · Cited by 112
Efficacy of Selected Natural Products as Therapeutic Agents against Cancer
Banerjee, S., Wang, Z., Mohammad, M., Sarkar, F. H., & Mohammad, R. M. (2008) · Journal of Natural Products · doi:10.1021/np0705716 · Cited by 105
Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A
Kuznetsov, G., Xu, Q., Rudolph-Owen, L., TenDyke, K., Liu, J., Towle, M. J., Zhao, N., Marsh, J. P., Agoulnik, S. I., Twine, N. C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1026 · Cited by 105
Cyanobacterial Toxin Degrading Bacteria: Who Are They?
Kormas, K. A., & Lymperopoulou, D. S. (2013) · BioMed Research International · doi:10.1155/2013/463894 · Cited by 104
Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungi
Zhang, J.-Y., Tao, L.-Y., Liang, Y.-J., Chen, L.-M., Mi, Y.-J., Zheng, L.-S., Wang, F., She, Z.-G., Lin, Y.-C., To, K. K. W., et al. (2010) · Marine Drugs · doi:10.3390/md8041469 · Cited by 103
New Drugs from the Sea: Pro-Apoptotic Activity of Sponges and Algae Derived Compounds
Ercolano, G., Cicco, P. D., & Ianaro, A. (2019) · Marine Drugs · doi:10.3390/md17010031 · Cited by 109
Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy
von Schwarzenberg, K., & Vollmar, A. M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.004 · Cited by 104
Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the “Supply Problem”
Gomes, N. G. M., Dasari, R., Chandra, S., Robert Kiss, A., & Kornienko, A. (2016) · Marine Drugs · doi:10.3390/md14050098 · Cited by 109
Pharmacokinetics of Marine-Derived Drugs
Shikov, A. N., Флисюк, Е. В., Obluchinskaya, E. D., & Pozharitskaya, O. N. (2020) · Marine Drugs · doi:10.3390/md18110557 · Cited by 102
Anticancer Drug Discovery from Microbial Sources: The Unique Mangrove Streptomycetes
Law, J. W., Law, L. N.-S., Letchumanan, V., Tan, L. T., Wong, S. H., Chan, K., Mutalib, N. A., & Lee, L. (2020) · Molecules · doi:10.3390/molecules25225365 · Cited by 106
Marine Bioactive Peptides—An Overview of Generation, Structure and Application with a Focus on Food Sources
Pavlićević, M., Maestri, E., & Marmiroli, M. (2020) · Marine Drugs · doi:10.3390/md18080424 · Cited by 104
Novel cytotoxic drugs: Old challenges, new solutions
Ismael, G., Rosa, D. D., Mano, M. S., & Awada, A. H. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.08.001 · Cited by 98
Coral and Coral-Associated Microorganisms: A Prolific Source of Potential Bioactive Natural Products
Vo, T., Dat, T. T. H., Vinh, L. B., Cường, L. C. V., Oanh, P. T. T., Hoang, H., Kim, Y. H., Anh, H. L. T., & Yang, S. Y. (2019) · Marine Drugs · doi:10.3390/md17080468 · Cited by 93
Secondary Metabolites of Marine Microbes: From Natural Products Chemistry to Chemical Ecology
Petersen, L.-E., Kellermann, M. Y., & Schupp, P. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-20389-4_8 · Cited by 94
Molecular Modeling of Potential Anticancer Agents from African Medicinal Plants
Ntie‐Kang, F., Nwodo, J. N., Ibezim, A., Simoben, C. V., Karaman, B., Ngwa, V. F., Sippl, W., Adikwu, M. U., & Meva’à, L. M. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5003697 · Cited by 89
Marine microorganisms as potential biofactories for synthesis of metallic nanoparticles
Manivasagan, P., Nam, S. Y., & Oh, J. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1137860 · Cited by 90
Enzyme Inhibitors from Marine Invertebrates
Nakao, Y., & Fusetani, N. (2007) · Journal of Natural Products · doi:10.1021/np060600x · Cited by 90
Marine natural products as targeted modulators of the transcription factor NF-κB
Folmer, F., Jaspars, M., Dicato, M. A., & Diederich, M. F. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.044 · Cited by 91
New Peptides Isolated from Lyngbya Species: A Review
Liu, L., & Rein, K. S. (2010) · Marine Drugs · doi:10.3390/md8061817 · Cited by 88
Antitumor and Antimicrobial Potential of Bromoditerpenes Isolated from the Red Alga, Sphaerococcus coronopifolius
Rodrigues, D., Alves, C., Horta, A., Pintéus, S., Silva, J., Culioli, G., Thomas, O., & Pedrosa, R. (2015) · Marine Drugs · doi:10.3390/md13020713 · Cited by 86
Recent Advances in the Total Synthesis of Chlorosulfolipids
Nilewski, C., & Carreira, E. M. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201101525 · Cited by 84
Visible-Light-Induced Regioselective Cross-Dehydrogenative Coupling of 2H-Indazoles with Ethers
Singsardar, M., Laru, S., Mondal, S., & Hajra, A. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b00318 · Cited by 84
Sepia Ink Oligopeptide Induces Apoptosis in Prostate Cancer Cell Lines via Caspase-3 Activation and Elevation of Bax/Bcl-2 Ratio
Huang, F., Yang, Z., Yu, D., Wang, J., Li, R., & Ding, G. (2012) · Marine Drugs · doi:10.3390/md10102153 · Cited by 84
Belamide A, a new antimitotic tetrapeptide from a Panamanian marine cyanobacterium
Simmons, T. L., McPhail, K. L., Ortega‐Barría, E., Mooberry, S. L., & Gerwick, W. H. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.03.082 · Cited by 84
Anticancer Agents from Diverse Natural Sources
Khazir, J., Riley, D. L., Pilcher, L. A., De-Maayer, P., & Mir, B. A. (2014) · Natural Product Communications · doi:10.1177/1934578x1400901130 · Cited by 81
Antimicrobial Activity of Heterotrophic Bacterial Communities from the Marine Sponge Erylus discophorus (Astrophorida, Geodiidae)
Graça, A. P., Bondoso, J., Gaspar, H., Xavier, J. R., Monteiro, M. C., de la Cruz, M., Oves‐Costales, D., Vicente, F., & Lage, O. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078992 · Cited by 82
Natural Proline-Rich Cyclopolypeptides from Marine Organisms: Chemistry, Synthetic Methodologies and Biological Status
Fang, W., Dahiya, R., Qin, H., Mourya, R., & Maharaj, S. B. (2016) · Marine Drugs · doi:10.3390/md14110194 · Cited by 82
Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry
Gao, G., Wang, Y., Hua, H., Li, D., & Tang, C. (2021) · Marine Drugs · doi:10.3390/md19070363 · Cited by 88
Combinatorial Strategies by Marine Cyanobacteria: Symplostatin 4, an Antimitotic Natural Dolastatin 10/15 Hybrid that Synergizes with the Coproduced HDAC Inhibitor Largazole
Taori, K., Liu, Y., Paul, V. J., & Luesch, H. (2009) · ChemBioChem · doi:10.1002/cbic.200900192 · Cited by 81
Lyngbyabellins K–N from Two Palmyra Atoll Collections of the Marine Cyanobacterium Moorea bouillonii
Choi, H., Mevers, E. E., Byrum, T., Valeriote, F. A., & Gerwick, W. H. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201200691 · Cited by 83
A Journey Under the Sea: The Quest for Marine Anti-Cancer Alkaloids
Tohmé, R., Darwiche, N., & Gali‐Muhtasib, H. U. (2011) · Molecules · doi:10.3390/molecules16119665 · Cited by 80
Antitubulin agents for the treatment of cancer – a medicinal chemistry update
Mahindroo, N., Liou, J., Chang, J., & Hsieh, H. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.5.647 · Cited by 79
New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Pejin, B., Jovanović, K., Mojović, M., & Savic, A. G. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660197 · Cited by 77
Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment
Beesoo, R., Neergheen, V. S., Bhagooli, R., & Bahorun, T. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.03.005 · Cited by 78
Endophytic Fungi of Marine Alga From Konkan Coast, India—A Rich Source of Bioactive Material
Kamat, S., Kumari, M., Taritla, S., & Jayabaskaran, C. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00031 · Cited by 77
Characterization of the Initial Enzymatic Steps of Barbamide Biosynthesis
Flatt, P. M., O'Connell, S. J., McPhail, K. L., Zeller, G., Willis, C. L., Sherman, D. H., & Gerwick, W. H. (2006) · Journal of Natural Products · doi:10.1021/np050523q · Cited by 77
Exploring Actinobacteria assemblages in coastal marine sediments under contrasted Human influences in the West Istria Sea, Croatia
Duran, R., Bielen, A., Paradžik, T., Gassie, C., Pustijanac, E., Cagnon, C., Hamer, B., & Vujaklija, D. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-4240-1 · Cited by 80
Epothilones in the treatment of cancer
Larkin, J., & Kaye, S. B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.6.691 · Cited by 76
Recent Advances in Small Peptides of Marine Origin in Cancer Therapy
Zhang, Q., Liu, Z.-D., Wang, Z., Wang, T., Wang, N., Wang, N., Zhang, B., & Yu-fen, Z. (2021) · Marine Drugs · doi:10.3390/md19020115 · Cited by 76
Site-specific chemical modification of antibody fragments using traceless cleavable linkers
Bernardes, G. J. L., Steiner, M., Hartmann, I., Neri, D., & Casi, G. (2013) · Nature Protocols · doi:10.1038/nprot.2013.121 · Cited by 75

Authors: Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H.
Affiliations: Oregon State University (US)
ORCID: McPhail, Kerry
Gerwick, William H.
Venue: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Published: 2005-02-01
Volume: 4
Issue: 2
Pages: 333-342
ISSN: 1535-7163 (ISSN-L)
1538-8514
DOI: 10.1158/1535-7163.333.4.2
OpenAlex: W2169637929
Cited by: 597
References: 77
Citations by year: 2026: 10 · 2025: 6 · 2024: 13 · 2023: 21 · 2022: 15 · 2021: 31 · 2020: 36 · 2019: 37 · 2018: 25 · 2017: 32 · 2016: 32 · 2015: 40 · 2014: 40 · 2013: 40 · 2012: 42
FWCI: 21.36
Type: journal article
Language: en
Open access: closed
Locations: Molecular Cancer Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Physical Sciences › Chemistry › Organic Chemistry › Isoquinoline Alkaloid Synthesis
Keywords: marine natural products, anticancer agents, dolastatin 10, halichondrin B, macrocyclic polyethers, marine peptides, structure elucidation, organic synthesis, clinical evaluation, mechanism of action
MeSH terms: Trabectedin, Polyether Polyketides, Animals, Antineoplastic Agents, Biological Products, Dioxoles, Ethers, Cyclic, Humans, Isoquinolines, Oceans and Seas, Tyrosine, Macrolides, Tetrahydroisoquinolines, Depsipeptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Marine natural products as anticancer drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks